RALPH HAYS: Open Payments
NPI 1528039922 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 18 payments from 10 companies in 2025. Trend: 2023 $468 · 2024 $388 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Kestra Medical Technology Services, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $42 |
| Boston Scientific Corporation | 1 | $41 |
| SCPHARMACEUTICALS INC. | 2 | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Cleerly, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: LEQVIO, Assure WCD, ELIQUIS, WATCHMAN, FUROSCIX, LifeVest, JARDIANCE, MOUNJARO.
Industry payments across LA — which companies pay providers there.
